CINECA IRIS Institutional Research Information System

DI MUNNO, OMBRETTA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.274
AS - Asia 2.955
EU - Europa 2.360
SA - Sud America 369
AF - Africa 237
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 3
Totale 11.205
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.073
CN - Cina 1.017
SG - Singapore 813
IT - Italia 810
HK - Hong Kong 552
SE - Svezia 366
BR - Brasile 334
BG - Bulgaria 248
UA - Ucraina 239
DE - Germania 204
CA - Canada 187
VN - Vietnam 142
TR - Turchia 128
KR - Corea 123
CH - Svizzera 121
FI - Finlandia 106
RU - Federazione Russa 100
NG - Nigeria 94
SN - Senegal 94
GB - Regno Unito 69
IN - India 67
AT - Austria 32
CI - Costa d'Avorio 25
FR - Francia 18
BD - Bangladesh 15
BE - Belgio 14
JP - Giappone 13
AR - Argentina 11
IQ - Iraq 11
ZA - Sudafrica 11
UZ - Uzbekistan 10
IR - Iran 9
EC - Ecuador 8
SA - Arabia Saudita 7
AU - Australia 6
ID - Indonesia 6
IE - Irlanda 6
MX - Messico 6
PK - Pakistan 6
SI - Slovenia 6
MA - Marocco 5
TW - Taiwan 5
AE - Emirati Arabi Uniti 4
LT - Lituania 4
MM - Myanmar 4
NL - Olanda 4
PE - Perù 4
VE - Venezuela 4
CR - Costa Rica 3
EU - Europa 3
LB - Libano 3
PH - Filippine 3
RO - Romania 3
UY - Uruguay 3
AZ - Azerbaigian 2
BO - Bolivia 2
EG - Egitto 2
ES - Italia 2
KE - Kenya 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LK - Sri Lanka 2
NP - Nepal 2
PA - Panama 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CL - Cile 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
GR - Grecia 1
GY - Guiana 1
HN - Honduras 1
JO - Giordania 1
KH - Cambogia 1
KW - Kuwait 1
LU - Lussemburgo 1
LV - Lettonia 1
MY - Malesia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PL - Polonia 1
PT - Portogallo 1
PY - Paraguay 1
TJ - Tagikistan 1
TN - Tunisia 1
YT - Mayotte 1
Totale 11.205
Salva come PNG Salva come JPEG
Città #
Hong Kong 544
Ashburn 540
Woodbridge 491
Santa Clara 479
Chandler 430
Ann Arbor 414
Milan 407
Singapore 401
Fairfield 333
Jacksonville 307
Sofia 246
Beijing 228
Houston 225
Shanghai 207
Ottawa 176
Hefei 161
Dallas 146
New York 125
Seoul 123
Wilmington 122
Seattle 118
Bern 117
Cambridge 115
Boardman 101
Nanjing 99
Dakar 94
Lagos 94
Lawrence 94
Princeton 94
Izmir 86
Medford 75
Los Angeles 62
Jüchen 56
Nanchang 52
Buffalo 50
Des Moines 42
Rome 41
Dong Ket 40
Dearborn 36
Istanbul 36
Vienna 32
Abidjan 25
Pune 25
Bremen 23
Grafing 23
São Paulo 23
Ogden 22
Kunming 21
San Diego 21
Shenyang 21
Ho Chi Minh City 19
Redwood City 19
Rio de Janeiro 18
Hebei 17
Changsha 15
Brussels 14
Munich 14
Orange 14
Redondo Beach 14
Serra 12
Boulder 11
Hangzhou 11
Jiaxing 11
Tokyo 11
Auburn Hills 10
Frankfurt am Main 10
Leipzig 10
Norwalk 10
Tianjin 10
Fuzhou 9
Tashkent 9
Hanoi 8
Lanzhou 8
Mumbai 8
Brasília 7
Ardabil 6
Columbus 6
Curitiba 6
Florence 6
Jinan 6
Johannesburg 6
Padova 6
Turku 6
Changchun 5
Council Bluffs 5
Greifswald 5
Paris 5
Porto Alegre 5
San Jose 5
San Mateo 5
Sydney 5
Baghdad 4
Betim 4
Bologna 4
Carignano 4
Centuripe 4
Fortaleza 4
Lecce 4
Livorno 4
London 4
Totale 8.266
Salva come PNG Salva come JPEG
Nome #
The synovial prostaglandin system in chronic inflammatory arthritis: differential effects of steroidal and nonsteroidal anti-inflammatory drugs. 203
Prevenzione e trattamento dell’osteoporosi indotta dagli inibitori dell’aromatasi. 181
Prevention of glucocorticoid-induced osteopenia: Effect of oral 25-hydroxyvitamin D and calcium 179
Effect of chronic treatment with ipriflavone in postmenopausal women with low bone mass 177
Double-blind, multicenter trial comparing acetyl l-carnitine with placebo in the treatment of fibromyalgia patients 167
Adverse events during longterm low-dose glucocorticoid treatment of polymyalgia rheumatica: a retrospective study. 167
Effects of glucocorticoid treatment on focal and systemic bone loss in rheumatoid arthritis 165
Risk factors for osteoporosis and fragility fractures in patients with systemic lupus erythematosus. 165
Lung function in essential mixed cryoglobulinemia: a short-term follow-up. 161
Adverse events during longterm low-dose glucocorticoid treatment of polymyalgia rheumatica: a retrospective study 159
Functional significance of renal prostacyclin and thromboxane A2 production in patients with systemic lupus erythematosus. 158
Quantitative ultrasound calcaneous measurements: normative data for the Italian population. the ESOPO study 158
Vitamin D status and response to treatment in post-menopausal osteoporosis 158
Determinants of bone turnover markers in healthy premenopausal women 157
Effect of cyclosporine A on bone density in female rheumatoid arthritis patients: results from a multicenter, cross-sectional study 156
[Renal tubular acidosis in essential mixed cryoglobulinemia]. 153
Determinants and Effects of Vitamin D Supplementation on Serum 25-Hydroxy-Vitamin D Levels in Patients with Rheumatoid Arthritis. 153
Lung involvement in essential mixed cryoglobulinemia. 151
Fluoxetin combined with cyclobenzaprine in the treatment of fibromyalgia 149
The effect of age,weight, and lifestyle factors on calcaneal quantitative ultrasound: the ESOPO study 149
Long-term prospective study of osteoporotic patients treated with percutaneous vertebroplasty after fragility fractures 148
Determinants of adherence to osteoporosis treatment in clinical practice 148
Randomized trial of effect of cyclical etidronate in the prevention of corticosteroid-induced bone loss 147
Glucocorticoid-induced osteoporosis: 2013 update. 146
Personalization of biologic therapy in patients with rheumatoid arthritis: Less frequently accounted choice-driving variables 146
Genetic epidemiology of Paget's disease of bone in italy: sequestosome1/p62 gene mutational test and haplotype analysis at 5q35 in a large representative series of sporadic and familial Italian cases of Paget's disease of bone 145
Diagnostica strumentale: la densitometria ossea 141
Risk factors for osteoporosis in female patients with systemic lupus erythematosus 141
Deflazacort versus Methylprednisolone in Polymyalgia Rheumatica. Reply 140
Ipriflavone prevents radial bone loss in postmenopausal women with low bone mass over two years 138
Glucocorticoid-induced osteoporosis and rheumatic diseases. Pathogenesis, prevention and treatment. (Osteoporosi da glucocorticoidi e malattie reumatiche. Patogenesi, prevenzione e trattamento) 137
Vitamin D deficiency in rheumatoid arthritis: prevalence, determinants and associations with disease activity and disability 137
A multicenter cross-sectional study on bone mineral density in rheumatoid arthritis 135
Efficacy of risedronate on clinical vertebral fractures within six months 132
Bisfosfonati e osteoporosi da glucocorticoidi up-to-date 2005 130
Glucocorticoid-induced osteoporosis: 2013 update. 127
Reduced bone mass and normal calcium metabolism in patients with systemic sclerosis 126
Effetti scheletrici ed extrascheletrici della vitamina D 125
Osteoporosi e malattie reumatiche: nuove opportunità terapeutiche. Up-to-date 2008 125
Optimizing Bisphosphonate Treatment Outcomes in Postmenopausal Osteoporosis: Review and Italian Experience 125
Effects of short-term, high dose, Heparin therapy on biochemical markers of bone resorption 124
Clinical equivalence between deflazacort oral drops and tablets in active rheumatoid arthritis 124
How the knowledge of fracture risk might influence adherence to oral therapy of osteoporosis in Italy: the ADEOST study 124
Il dolore cronico nelle malattie reumatiche. Fisiopatologia e indicazioni di terapia. 121
Approccio diagnostico dell’osteoporosi postmenopausale 120
Efficacy of ibandronate: a long term confirmation 118
Association of quantitative heel ultrasound with history of osteoporotic fractures in elderly men: The ESOPO study 118
Single infusion of neridronate (6-amino-1hydroxy-hexylidene-1,1-bisphosphonate) in patients with active rheumatoid arthrites:Effects on disease activity and bone resorption markers 116
La salute dell’osso dall’infanzia all’età adulta 114
Disease-modifying antirheumatic drugs and bone mass in rheumatoid arthritis 114
La vitamina D attraverso un secolo 112
Validation and further development of the WHO 10-year fracture risk assessment tool in Italian postmenopausal women: project rationale and description 112
Intramuscular neridronate in postmenopausal women with low bone mineral density 112
High rate of vertebral refracture after vertebroplasty in patients taking glucocorticoids: a prospective two-year study 112
Epidemiologia dell’osteoporosi da glucocorticoidi 111
Vertebral bone mineral density changes in female rheumatoid arthritis patients treated with low-dose methotrexate 110
I percorsi diagnostico-terapeutici assistenziali nella gestione del paziente con frattura. 110
Ipovitaminosi D nell’anziano in Italia e la sua prevenzione 109
Osteoporosi e malattie reumatiche: terapie di fondo 108
Long-term prospective study of osteoporotic pacients treated with percutaneous vertebroplasty after fragility fractures. 108
Multicentric Castleman's disease in a patient with primary Sjögren's syndrome. 106
Fisiopatologia dell’osteoporosi da glucocorticoidi e bisfosfonati. Up-to-date 2006 103
Incidenza e conseguenze dell’ipovitaminosi D. Up-to-date 2007 102
Study of vitamin D status of rheumatoid arthritis patients. (Studio dello stato vitaminico D in pazienti affetti da artrite reumatoide. Razionale e disegno della rilevazione cross-sectional programmata dal gruppo SIR per lo studio dell’osteoporosi e delle malattie metaboliche dello scheletro) 101
Razionale delle future terapie dell’osteoporosi 98
Terapia dell’osteoporosi. Presente e futuro 96
Bisfosfonati ed effetti scheletrici degli inibitori dell’aromatasi 96
Eventi avversi dei bisfosfonati 94
Ibandronato : conferma dell’efficacia a lungo termine 92
Meccanismi di rimodellamento osseo nelle malattie reumatiche 92
Prevenzione e trattamento dell’osteoporosi indotta da glucocorticoidi nella realtà italiana e in quella internazionale. Rassegna 92
Deflazacort vs. methylprednisolone in Polymyalgia Rheumatica: clinical equivalence and relative antiinflammatory potency of different treatment regimens 92
Il risedronato 90
Bioelectrical impedance analysis (BIA) is a reliable method to evaluate lean body mass in maintenance hemodialysis patients: comparison with dual-energy emission x-rays absorptiometry (DXA). 90
Risedronato e trattamento dell’osteoporosi 89
Minor connectivitis and the mixed connective tissue disease 89
L’osteoporosi nelle malattie reumatiche 88
Gli effetti avversi della terapia dell’osteoporosi 87
Nuove opportunità di prevenzione e trattamento del’osteoporosi indotta da glucocorticoidi 86
Farmaci biologici antireumatici 85
Liver involvement in essential mixed cryoglobulinemia. 84
Nuove frontiere farmacologiche: l’osteoporosi 83
Methotrexate and bone mass 83
Sistema nervoso autonomo e densità minerale ossea: studio dei polimorfismi dei recettori β1 e β2-adrenergici in una popolazione femminile 83
Effect of low dose methotrexate on bone density in women with rheumatoid arthritis: results from a multicenter cross-sectional study 81
Osteoporosi : i farmaci efficaci per combatterla ci sono ma vanno presi e presi correttamente! 80
Update sull’osteoporosi cortisonica 80
Effetti scheletrici della vitamina D 79
Influenza sulla funzione cartilaginea e sulle malattie degenerative articolari delle adipochine 78
L’osteoporosi nelle malattie reumatiche 77
Vitamina D e malattie reumatiche 77
Osteociti e vascolarizzazione ossea nella fragilità scheletrica indotta da glucocorticoidi. 71
Osteoporosi : terapie a confronto. Introduzione 69
Prevenzione e trattamento dell’osteoporosi indotta da glucocorticoidi: recenti evidenze 68
Totale 11.263
Salva come PNG Salva come JPEG
Categoria #
all - tutte 29.355
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.355
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021469 0 0 0 0 0 32 67 73 56 48 61 132
2021/2022808 5 74 10 71 172 109 6 43 31 9 55 223
2022/20231.254 148 110 83 124 209 187 2 81 257 5 42 6
2023/20241.190 241 169 156 101 168 159 21 32 17 9 37 80
2024/20252.652 6 104 9 120 322 260 301 158 257 350 272 493
2025/20261.330 159 326 232 143 247 223 0 0 0 0 0 0
Totale 11.263